Suppression of allergen reactive Th2 mediated responses and pulmonary eosinophilia by intranasal administration of an immunodominant peptide is linked to IL-10 production

Vaccine

Volumn 21, Issue 5-6, 2003, Pages 549-561

  Hall, Gillian ^a   Houghton, Christian G ^b   Rahbek, Janne Uldal ^b   Lamb, Jonathan R ^a   Jarman, Elizabeth R ^a,b  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ALK ABELLÓ   (Denmark)

Author keywords

Allergy; Immunoregulation; In vivo animal models; Microencapsulated antigen

Indexed keywords

ALLERGEN; EPITOPE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 5; PEPTIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DERMATOPHAGOIDES PTERONYSSINUS; IMMUNOLOGICAL TOLERANCE; IMMUNOREGULATION; INFLAMMATION; LOEFFLER PNEUMONIA; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH2 CELL;

ALLERGENS; ANIMALS; ASTHMA; BRONCHOALVEOLAR LAVAGE FLUID; DERMATOPHAGOIDES FARINAE; EOSINOPHILS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; IMMUNIZATION; IMMUNODOMINANT EPITOPES; INTERLEUKIN-10; INTERLEUKIN-13; INTERLEUKIN-4; INTERLEUKIN-5; LEUKOCYTE COUNT; LUNG; MICE; MICE, INBRED C57BL; PEPTIDES; PULMONARY EOSINOPHILIA; TH1 CELLS; TH2 CELLS;

EID: 0037449504     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00394-8     Document Type: Article

References (40)

1. Robinson D.S., Hamid Q., Ying S.et al. Predominant TH2 like branchoalveolar T-lymphocyte population in atopic asthma. New Engl. J. Med. 326:1992;298.
2. Hamid Q.A., Minshall E.M. Molecular pathology of allergic disease. Part I: Lower airway disease. J. Allergy Clin. Immunol. 105:2000;20-36.
3. van Neerven R.J.J., Wikbor T., Lund G.et al. Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation. J. Immunol. 163:1999;2944-2952.
4. Furin M.J., Norman P.S., Creticos P.S.et al. Immunotherapy decreases antigen-induced eosinophil migration into the nasal cavity. J. Allergy Clin. Immunol. 88:1999;27-32.
5. Varney V.A., Hamid Q.A., Gaga M.et al. Influence of grass pollen immunotherapy on cellular infiltration and cytokine mRNA expression during allergen-induced late-phase cutaneous response. J. Clin. Invest. 92:1993;644-651.
6. Secrist H., Chelen C.J., Wen Y., Marshall J.D., Umetsu D.T. Allergen immunotherapy decreases interleukin 4 production in CD4 T cells from allergic individuals. J. Exp. Med. 178:1993;2123-2130.
7. Akdis C.A., Akdis M., Blesken T.et al. Epitope-specific T cell tolerance to phospholipase A2 in bee venom immunotherapy and recovery by IL-2 and IL-15 in vitro. J. Clin. Invest. 98:1996;1676-1683.
8. Weiner H.L. Oral tolerance for the treatment of autoimmune diseases. Annu. Rev. Med. 48:1997;341-351.
9. Metzler B., Wraith D.C. Mucosal tolerance in a murine model of experimental autoimmune encephalomyelitis. Annu. New York Acad. Sci. 778:1996;228-242.
10. Frew A.J., Smith H.E. Sublingual immunotherapy. J. Allergy Clin. Immunol. 107:2001;441-444.
11. + T cell-mediated but MHC class II-restricted CD4+ T cell-dependent immune deviation resulting in selective immunosuppression of immunoglobulin E production. J. Exp. Med. 178:1993;889-899.
12. Wiedermann U., Jahn-Schmid B., Bohle B.et al. Suppression of antigen specific T and B cell responses by intranasal or oral administration of recombinant Bet v 1, the major birch pollen allergen, in a murine model of type I allergy. J. Allergy Clin. Immunol. 103:1999;102-110.
13. Astori M., von Garnier C., Kettner A., Dufour N., Corradin G., Spertini F. Inducing tolerance by intransal administration of long peptides in naive and primed CBA/J mice. J. Immunol. 165:2000;3497-3505.
14. Muller U, Akdis CA, Fricker M, et al. Successful immunotherapy with T-cell epitope peptides of bee venom phopholipase A2 induces specific T-cell anergy in patients allergic to bee venom. 1998;101:747-54.
15. Pene J., Desroches A., Paradis L.et al. Immunotherapy with Fel d 1 peptides decreases IL-4 release by peripheral blood T cells of patients allergic to cats. J. Allergy Clin. Immunol. 102:1998;571-578.
16. Haselden B.M., Kay A.B., Larche M. Immunoglobulin E-independent major histocompatablility complex-restricted T cell peptide epitope-induced late asthmatic reactions. J. Exp. Med. 189:1999;1885-1894.
17. Hoyne G.F., Callow M.G., Kuo M.-C., Thomas W.R. Inhibition of T cell responses by feeding peptides containing major and cryptic epitopes. Studies with the Der p 1 allergen. Immunology. 83:1994;190-195.
18. Higgins J.A., Thorpe C.J., Hayball J.D., O'Hehir R.E., Lamb J.R. Overlapping T-cell epitopes in the group I allergen of Dermatophagoides species restricted by HLA-DP and HLA-DR class II molecules. J. Allergy Clin. Immunol. 93:1994;891-899.
19. Hoyne G.F., O'Hehir R.E., Wraith D.C., Thomas W.R., Lamb J.R. Inhibition of T cell and antibody responses to house dust mite allergen by inhalation of the dominant T cell epitope in naive and sensitised mice. J. Exp. Med. 178:1993;1783-1788.
20. Janssen E.M., van Osoterhout A.J., Nijkamp F.P., van Eden W., Wauben M.H.M. The efficacy of immunotherapy in an experimental murine model of allergic asthma is related to the strength and site of T cell activation during therapy. J. Immunol. 165:2000;7207-7214.
21. Benson J.M., Campbell K.A., Guan Z.et al. T-cell activation and receptor downmodulation precede deletion induced by mucosally administered antigen. J. Clin. Invest. 106:2000;1031-1038.
22. MacKenzie J.R., Mattes J., Dent L.A., Foster P.S. Eosinophils promote allergic disease of the lung by regulating CD4+ Th2 lymphocyte function. J. Immunol. 167:2001;3146-3155.
23. Grunig G., Warnock M., Eakil A.E.et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science. 282:1998;2261-2262.
24. Tsitoura D.C., Blumenthal R.L., Berry G., DeKruyff R.H., Umetsu D.T. Mechanisms preventing allergen-induced airway hyperreactivity: role of tolerance and immune deviation. J. Allergy Clin. Immunol. 106:2000;239-246.
25. Hansen G., Berry G., DeKruyff R.H., Umetsu D.T. Allergen-specific Th1 cells fail to counterbalance Th2 cell-induced airway hyperreactivity but cause severe airway inflammation. J. Clin. Invest. 103:1999;175-183.
26. Korsgren M., Erjefalt J.S., Korsgren O., Sunder F., Persson C.G. Allergic eosinophil-rich inflammation develops in lungs and airways of B cell-deficient mice. J. Exp. Med. 185:1997;885-892.
27. Hamelmann E., Takeda K., Schwartz J., Vella A.T., Irvin C.G., Gelfand E.W. Development of eosinophilic airway inflammation and airway hyperresponsiveness requires interleukin-5 but not immunoglobulin E or B lymphocytes. Am. J. Respir. Cell Mol. Biol. 21:1999;480-489.
28. Hurst S.D., Seymour B.W.P., Muchamuel T., Kurup V.P., Coffman R.L. Modulation of inhaled antigen-induced IgE tolerance by ongoing Th2 responses in the lung. J. Immunol. 166:2001;4922-4930.
29. + immunoregulatory T cells is antigen non-specific. J. Immunol. 164:2000;183-190.
30. + T cells. Int. Immunol. 12:2000;177-185.
31. Haneda K., Sano K., Tamura G.et al. Transforming growth factor-β-secreted from CD4+ T cells ameliorates antigen-induced eosinophilic inflammation. Am. J. Respir. Cell Mol. Biol. 21:1999;268-274.
32. Burkhart C., Liu G.Y., Anderton S.M., Netzler B., Wraith D.C. Peptide-induced T cell regulation of experimental autoimmune encephalomyelitis: a role for IL-10. Int. Immunol. 11:1999;1625-1634.
33. Akdis C.A., Blesken T., Akdis M., Wuthrich B., Blaser K. Role of interleukin 10 in specific immunotherapy. J. Clin. Invest. 102:1998;98-106.
34. Akbari O., DeKruyff R.H., Umetsu D.T. Pulmonary dendritic cells producing IL-10 mediate tolerance induced by respiratory exposure to antigen. Nature Immunol. 2:2001;725-731.
35. Asseman C., Mauze S., Leach M.W., Coffman R.L., Powrie F. An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med. 190:1999;995-1004.
36. Groux H., Bigler M., O'Garra A.et al. A CD4+ T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature. 389:1997;737-742.
37. Cottrez F., Hurst S.D., Coffman R.L., Groux H. T regulatory cells 1 inhibit a Th2-specific response in vivo. J. Immunol. 165:2000;4848-4853.
38. Zuany-Amorim C., Haile S., Leduc D.et al. Interleukin-10 inhibits antigen-induced cellular recruitment into the airways of sensitised mice. J. Clin. Invest. 95:1995;2644-2651.
39. Steinbrink K, Wolfl M, Jonuleit H, Knop J, Enk AH. Induction of Tolerance by IL-10 treated dendritic cells. 1997;159:4772-80.
40. Jonuleit J., Schmitt E., Schuler G., Knop J., Enk A.H. Induction of interleukin 10-producing, non-proliferating CD4 (+) T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J. Exp. Med. 192:2000;1213-1222.